Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis

Author:

Hsu Christine C.123ORCID,Dodge Jennifer L.45ORCID,Weinberg Ethan6ORCID,Im Gene7ORCID,Ko Jimin1ORCID,Davis William2ORCID,Rutledge Stephanie7ORCID,Dukewich Matthew6ORCID,Shoreibah Mohamed8ORCID,Aryan Mahmoud8ORCID,Vosooghi Aidan5ORCID,Lucey Michael9ORCID,Rice John9ORCID,Terrault Norah A.45ORCID,Lee Brian P.45ORCID

Affiliation:

1. Georgetown University School of Medicine, Washington, District of Columbia, USA

2. Medstar Georgetown University Hospital, Washington, District of Columbia, USA

3. Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA

4. University of Southern California, Los Angeles, California, USA

5. University of Southern California, Keck School of Medicine, Los Angeles, California, USA

6. University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA

7. Icahn School of Medicine at Mount Sinai, New York City, New York, USA

8. University of Alabama at Birmingham School of Medicine, Birmingham Alabama, USA

9. University of Wisconsin School of Medicine, Madison, Wisconsin, USA

Abstract

Background: Early liver transplantation for alcohol-associated hepatitis is controversial in part because patients may recover, and obviate the need for liver transplantation. Methods: In this retrospective study among 5 ACCELERATE-AH sites, we randomly sampled patients evaluated and then declined for liver transplantation for alcohol-associated hepatitis. All had Model of End-Stage Liver Disease (MELD) >20 and <6 months of abstinence. Recompensation was defined as MELD <15 without variceal bleeding, ascites, or overt HE requiring treatment. Multilevel mixed effects linear regression was used to calculate probabilities of recompensation; multivariable Cox regression was used for mortality analyses. Results: Among 145 patients [61% men; median abstinence time and MELD-Na was 33 days (interquartile range: 13–70) and 31 (interquartile range: 26–36), respectively], 56% were declined for psychosocial reasons. Probability of 30-day, 90-day, 6-month, and 1-year survival were 76% (95% CI, 68%–82%), 59% (95% CI, 50%–66%), 49% (95% CI, 40%–57%), and 46% (95% CI, 37%–55%), respectively. Probability of 1-year recompensation was low at 10.0% (95% CI, 4.5%–15.4%). Among patients declined because of clinical improvement, 1-year probability of recompensation was 28.0% (95% CI, 5.7%–50.3%). Among survivors, median MELD-Na at 30 days, 90 days, and 1-year were 29 (interquartile range: 22–38), 19 (interquartile range : 14–29), and 11 (interquartile range : 7–17). Increased MELD-Na (adjusted HR: 1.13, p<0.001) and age (adjusted HR: 1.03, p<0.001) were associated with early (≤90 d) death, and only history of failed alcohol rehabilitation (adjusted HR: 1.76, p=0.02) was associated with late death. Conclusions: Liver recompensation is infrequent among severe alcohol-associated hepatitis patients declined for liver transplantation. Higher MELD-Na and age were associated with short-term mortality, whereas only history of failed alcohol rehabilitation was associated with long-term mortality. The distinction between survival and liver recompensation merits further attention.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3